FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products

Drug Industry Daily
A A
The FDA released a list of alternative suggestions for complying with CGMP requirements for drug combination products that covers stability testing, release for distribution, reserve samples and special testing requirements.

To View This Article:

Login

Subscribe To Drug Industry Daily